Clinical Trial Update: Effects of Psilocybin in Obsessive Compulsive Disorder [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase 1 clinical trial evaluating the effects of psilocybin for obsessive-compulsive disorder, sponsored by Johns Hopkins Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Obsessive-Compulsive Disorder | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING